Member Profile

Founded in 2014, Sinew Pharma is a biopharmaceutical company based at National Biotechnology Reserach Park in Taipei, Taiwan. The company focuses on two major medical need: (NASH) and Liver damage caused by Acetaminophen.
Sinew uses hepatic metabolic enzymes as a platform to perform layers of screening from in-vitro, in-vivo, toxicology, clinical trials, and optimizes the absorption, distribution, and metabolism of drugs. Sinew successfully developed six new drug candidates to treat NASH and to prevent acetaminophen hepatotoxicity.